The Challenge of Diabetes

 

Why isn’t there a simple, inexpensive test that can immediately tell someone his or her risk for developing diabetes? This goal has been achieved for many other common health situations, beginning with the pregnancy test and now available across a wide range of conditions. There is a clear unmet need for such a diabetes test, something with the potential to help the world address what many believe is the major healthcare issue of our time.

 

Only in the past few years have governments, major health care providers, and pharmaceutical companies begun to respond to the scale of the looming diabetes disaster by focusing on finding effective programs for diabetes prevention and control. The way forward was indicated beginning almost 15 years ago, when the Asheville Project and the Diabetes Ten City Challenge demonstrated that a community–based prevention strategy based on monthly counseling improved patient outcomes, conserved expensive medical resources and more than paid for itself in reduced medical costs and increased worker productivity.

 

Passage of the Patient Protection and Affordable Care Act (PPACA - Obamacare) in 2010 has had the most significant impetus for the exploration and adoption of prevention–based approaches to diabetes. The PPACA called for the creation of the National Prevention Council, which in turn released the National Prevention Strategy in June of 2011 – a document that outlines a detailed policy for the implementation of prevention–based programs that will improve health and significantly reduce healthcare costs.

 

Evidence-based diabetes prevention programs based on monthly counseling are now widespread throughout the U.S., with community organizations such as the YMCA supported by national organizations such as the American Association of Diabetes Educators. The health insurance industry has embraced the logic of diabetes prevention and is in the process of implementing a national strategy for diabetes prevention.

 

 

 

 

Additional Sources

 

           American Diabetes Association ADA

           International Diabetes Federation

           American Association of Clinical Endocrinologists

 

Diabetes Prevention – Challenge and Opportunity

   Company                       Product                               Technology                           Markets                                  Investor Relations

   Company Overveiw           G1A Test                                Overview                                Overview                                  Shareholder Website

   Management                   ACR Test                                 G1A Test                                G1A Test                                  Corporate Profile & Governance

   Advisory Board                SimplySure PT-INR Test             ACR Test                                ACR Test                           

                                                                                    SimplySure PT-INR Test            SimplySure PT-INR Test       

                                                                                    Intellectual Property                                                      

   

  Publications                                    Contact               

  Corporate Information Series                                  

  Scientific Reviews  

                                                                                                                                                                              

                              

 

 

 

 

 

© 2016 by Epinex Diagnostics Inc

Epinex-G1A-Glycated Albumin-Monthly Diabetes Test

FOLLOW US:

  • w-facebook
  • Twitter Clean
  • White LinkedIn Icon